RFA Therapy near Little Rock, AR
If you have additional questions about RFA Therapy and treating Barrett's Esophagus, or would like to schedule an appointment, contact Arkansas Heartburn Treatment Center at (501) 250-2020.
How is Barrett’s esophagus treated?
Treatment options vary, depending on the stage or severity of Barrett’s esophagus. The following additional risk factors may increase your risk of Barrett’s esophagus progressing to esophageal cancer:6
- Family history of Barrett’s esophagus or esophageal adenocarcinoma
- Long-segment disease
- Early disease onset
One treatment is called radiofrequency ablation. With ablation, tissue is heated until it is no longer viable or alive. Physicians have been using various forms of this technique for nearly a century to treat a number of cancerous and pre-cancerous conditions, as well as to control bleeding.
We use the Barrx™ radiofrequency ablation (RFA) system. This system delivers radiofrequency energy in a unique way, optimizing the removal of diseased tissue while minimizing injury to normal esophagus tissue. With this treatment, there’s a more than 90 percent likelihood of removing pre-cancerous (dysplastic Barrett’s esophagus) tissue from the esophagus.7
We will schedule a follow-up appointment within two months to assess the response to the treatment and to treat any remaining Barrett’s tissue. From there, we will continue to watch for any reoccurrence.
A note about GERD
RFA does not cure GERD or related symptoms. We will continue to guide you regarding long-term GERD therapy, if needed.
Where can I learn more about RFA?
Visit www.learnaboutbarretts.com to learn more.
What can I do if I’m concerned about Barrett’s esophagus?
We’re here to help. Please contact us to schedule a consultation.
1. Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett’s esophagus: a review of the literature. J Gastrointest Surg. 2011;15:708-18.
2. Spechler SJ, Souza RF. Barrett’s esophagus. NEJM. 2014;371:836-45.
3. Dymedex Market Development Consulting, GERD Sizing and Segmentation for pH Testing, February 13 2015.
4. Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373(9666):850-61.
5. Dymedex Market Development Consulting, GERD Sizing and Segmentation for pH Testing. February 13, 2015.
6. Spechler S. et al. Barrett’s Esophagus. N Engl J Med 2014; 371:836-45.
7. Orman et al. Efficacy and Durability of RFA for BE: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 2013;11:1245-1255.
Results may vary. Keep in mind that all treatment and outcome results are specific to the individual patient. Please consult your physician for a full list of indications, warnings, precautions, adverse events, clinical results, and other important medical information.
Caution: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. Rx only.
Risk Information: The following are transient side effects that may be expected after treatment: chest pain, difficulty swallowing, painful swallowing, throat pain and/or fever. Complications observed at a very low frequency include: mucosal laceration, minor and major acute bleeding, stricture, perforation, cardiac arrhythmia, pleural effusion, aspiration, and infection. Potential complications that have not been observed include: death. Please refer to the product user manual or medtronic.com/gi for detailed information.